BCL2 and neuroblastoma: Moreover, growth and therapeutic resistance in neuroblastoma was shown to be mediated through the miR-15a/16-1–ERK and Bcl-2/Cyclin D1 pathways [45] which supports our findings that miR-15a-5p may play a pivotal role in ECD development.